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Abstract The signal transducer and activator of transcription
(STAT) proteins deliver signals from the cell membrane to the
nucleus. An N-terminally truncated fragment of murine Stat3L,
Stat3Ltc (127^722), was produced in bacteria. STAT proteins
must be specifically phosphorylated at a single tyrosine residue
for dimerization and DNA binding. Therefore, Stat3Ltc was
coexpressed with the catalytic domain of the Elk receptor
tyrosine kinase. Stat3Ltc was quantitatively phosphorylated by
this kinase domain. Gel filtration chromatography revealed a
Stat3Ltc dimer. Y705 was identified as the major phosphorylated
residue of Stat3Ltc. This corresponds to the tyrosine residue
which is phosphorylated by the Janus kinase in vivo. The
phosphorylated Stat3Ltc specifically bound to DNA binding
sites. The described protocol allows the production of large
amounts of activated protein for biochemical and pharmaceutical
studies.
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1. Introduction
Signal transducers and activators of transcription (STATs)
constitute a family of eukaryotic transcription factors [1].
Their latent, cytoplasmic form is activated by phosphorylation
of a single tyrosine residue [2]. This activation step is triggered
by the binding of growth factors, hormones or cytokines to
their receptors [3]. The tyrosine kinases involved in activation
are either intrinsic activities of ligand-activated transmem-
brane receptors or Janus kinases which are associated with
cytokine receptors [4,5]. After tyrosine phosphorylation the
STATs homo- or heterodimerize, translocate to the nucleus
and regulate gene expression by binding to speci¢c response
elements [2,6].
So far seven mammalian STATs have been identi¢ed. In
most cases the targeted disruption of these STAT genes in
mice led to phenotypes in various organs, including the mam-
mary gland and the immune system [1,7]. Initial studies in
cultured cells suggested that STATs can be activated by a
large number of polypeptides. More recent studies, however,
indicate that the STATs can be di¡erentially activated de-
pending on the subset of cell surface receptors in speci¢c
tissues [8]. Therefore the STATs combine activation by a large
array of di¡erent signals with tissue dependent speci¢city. The
STAT signalling pathway from the cell membrane to the nu-
cleus is also a comparably direct signal transduction pathway.
This has turned the STATs into important targets for drug
development with the aim to modulate a large number of
cellular functions.
Biochemical and molecular genetic investigations estab-
lished a common structural organization of the STAT pro-
teins. The N-terminal part of the STATs, named N-domain, is
responsible for dimer dimerization on clustered DNA binding
sites and interaction with other proteins [9,10]. The DNA
recognition domain was located between residues 300 and
500 [11]. The highly conserved residues 600^700 form a Src
homology 2 (SH2) domain [12]. This SH2 domain mediates
the interaction with the cytoplasmic domain of the receptor
through binding to phosphotyrosine residues as well as the
dimerization of the STATs through reciprocal binding of
the phosphotyrosine residue following the SH2 domain [1].
The C-terminus of the STATs contains long stretches of acidic
residues which constitute the transactivation domain [9,10].
For several STATs splice variants have been identi¢ed within
this domain [13^15]. Recently these studies have been matched
by X-ray structures (Fig. 1). The N-domain of human Stat4
shows a hook-like structure and forms stable dimers [16]. The
complementary crystal structures of N-terminally truncated
fragments of the murine Stat1 and Stat3L dimers in complex
with DNA have also been reported [17,18].
The availability of large amounts of active Stat protein has
been a prerequisite for structural studies. In this paper we
describe the expression of mg amounts of N-terminally trun-
cated active Stat3L in Escherichia coli and a simple three-step
puri¢cation protocol. We achieved speci¢c phosphorylation
by the coexpression of the protein-tyrosine kinase domain of
the Elk receptor in bacteria[19]. The puri¢ed protein was used
for co-crystallization with DNA oligonucleotides and led to
the structure determination of the Stat3L :DNA complex [17].
Our procedure should be applicable to other Stat proteins and
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allows the large-scale expression of active Stats for structural
and biochemical studies as well as large-scale drug screening.
2. Materials and methods
2.1. Expression and puri¢cation of Stat3Ltc
A C-terminal fragment of the murine Stat3L cDNA, starting at
residue G127, was ampli¢ed by polymerase chain reaction (PCR) us-
ing the primers 5P-dGGGATCTACTTCCATATGGGCCAGGC-
CAACCACC and 5P-dGGAATTCATCATTTCCAAACTGCATCA-
ATGAATGGTGTCACACAGATGAACTTGGT (restriction sites
underlined). The second primer was designed to start 20 bases up-
stream of the splice site between Stat3 and Stat3L [13,14], because the
template for the PCR reaction was a cDNA encoding Stat3. Therefore
the primer had to encode the di¡ering seven amino acids after the
splice site at P713.
The PCR fragment was digested with NdeI/EcoRI and cloned into
the expression vector pET32a (Novagen). The resultant expression
plasmid pET32aStat3Ltc was transformed into the E. coli strain
BL21(DE3)TBK1 (Stratagene). For expression 10 ml of an overnight
culture in 2UYT broth [20], supplemented with 100 Wg/ml ampicillin
and 12 Wg/ml tetracycline, was diluted 1/50 into 0.5 l of LB broth [20]
supplemented with the same antibiotics. The culture was grown at
37‡C to A600 = 0.3. Then the temperature was switched to 21‡C. At
mid-log phase (A600 = 0.6^0.7) the expression was induced by adding
1 mM isopropyl-1-thio-L-D-galactopyranoside. The cells were har-
vested 5 h after induction by centrifugation and redissolved in 1 l
of kinasing medium (1UM9 [20], 1 mM MgSO4, 11mM D(+)-glucose,
0.1% (w/v) casamino acids (Difco), 1.5 WM thiamine-HCl, 53 WM 3L-
indoleacrylic acid), supplemented with 50 Wg/ml ampicillin and 12.5
Wg/ml tetracycline. The 3L-indoleacrylic acid induces the expression of
the Elk receptor protein-tyrosine kinase domain under the control of
the trp promoter [21]. This culture was grown for another 2.5 h at
37‡C. Finally the cells were harvested by centrifugation and the pellet
was stored at 380‡C.
The cells were resuspended in ice-cold extraction bu¡er (20 mM
HEPES-HCl, pH 7.6, 0.1 M KCl, 10% glycerol, 1 mM EDTA, 10
mM MnCl2, 20 mM DTT, 0.5 mM PMSF; 10 ml/g cells). The lysis
was performed by ultrasonication and the lysate was centrifuged at
27 000Ug for 45 min at 4‡C. To remove nucleic acids polyethylene-
imine (0.1% ¢nal) was added to the ice-cooled, stirred supernatant.
The resulting suspension was stirred on ice for another 15 min and
then centrifuged for 20 min at 27 000Ug. Ammonium sulfate was
slowly added to the supernatant up to 35% saturation while the sol-
ution was stirred on ice. The precipitated protein was collected by
centrifugation, redissolved in 0.3 ml of bu¡er D (20 mM HEPES-
HCl, pH 7.0, 200 mM NaCl, 10 mM MgCl2, 5 mM DTT, 0.5 mM
PMSF) and dialyzed over night at 4‡C against 0.5 l of bu¡er D.
After dialysis the protein was loaded on a Pharmacia Superose 12
HR 10/30 column, which had been equilibrated with bu¡er D. The
protein was eluted at a £ow rate of 0.5 ml/min. The peak fractions
were analyzed by a 10% SDS-polyacrylamide gel. Fractions of highest
purity were combined and stored on ice for further use. Typical yields
were 5 mg of s 95% pure (as judged by Coomassie stain) Stat3Ltc
protein from 1 l of starting culture.
To obtain 32P-labelled Stat3Ltc, the protein was expressed in a 0.15
l culture as described above. After harvesting the cells were redis-
solved in 0.3 l of a modi¢ed kinasing medium in which sodium phos-
phate was replaced by 50 mM Tris-HCl, pH 7.0. In addition 1 mCi of
[32P]sodium phosphate (Amersham) was added to the culture. Other-
wise the expression conditions for the Elk receptor tyrosine kinase
domain were as described above. The radiolabelled Stat3Ltc protein
was puri¢ed by preparative 10% SDS-polyacrylamide gel electropho-
resis. 30 Wg of protein was loaded per well on the gel (1.5 mm). After
electrophoretic separation the protein was blotted onto nitrocellulose
(Schleicher and Schuell, 60 V for 1 h) in blotting bu¡er (10 mM
CAPS, pH 11, 10% methanol). The nitrocellulose was stained with
Ponceau S dye (Merck) and the bands corresponding to Stat3Ltc were
cut out. The nitrocellulose pieces were completely destained by wash-
ing with double distilled water and dried. The speci¢c activity of the
puri¢ed 32P-labelled Stat3Ltc was 0.53 WCi/pmol protein.
2.2. Enzymatic digestion of 32P-labelled Stat3Ltc
The radioactive ¢lter fragments containing Stat3Ltc were washed
three times with H2O, blocked with 0.5% w/v polyvinylpyrrolidone-
40 (Sigma) in 100 mM acetic acid and washed again 10 times with
H2O. The ¢lter fragments were sliced into small pieces and placed in a
microcentrifuge tube. Two proteolytic digestion methods were used:
trypsin was used exclusively or AspN and trypsin were added sequen-
tially. The trypsin digestion was performed as previously described
[22]. The sequential digestion with AspN/trypsin was performed in
10 mM N-ethylmorpholine, 1% (w/v) Zwittergent 3-16 (Calbiochem)
digestion bu¡er, pH 7.9. The digestion bu¡er was added until the
membrane pieces were covered, subsequently 0.5 Wg AspN was added.
The AspN digestion was performed overnight at 37‡C. Next, 2 Wg
trypsin was added to the same solution and left to digest at 37‡C
for 3 h. After the sequential digestion the microcentrifuge tube was
sonicated for 15 s. and centrifuged on a bench-top centrifuge at 14 000
rpm for 1 min. Supernatant was collected and the membrane pieces
were washed once with digestion bu¡er (without zwittergent), soni-
cated and centrifuged. The supernatant was collected, pooled with the
¢rst supernatant and vacuum dried.
2.3. Liquid chromatography tandem mass spectrometric (LC-MS/MS)
analysis of radiolabelled peptides
Peptides were separated on a Michrom Ultrafast Microprotein an-
alyzer (Michrom Bioresources, Auburn, CA) equipped with a Mi-
chrom Reliasil, 0.5 mm diameter, 300 Aî , 5 Wm, C18 column. A linear
gradient was developed for 45 min, at 50 Wl/min from bu¡er A (2%
CH3CN, 98% H2O, 0.4% CH3COOH, 0.005% C4HF7O2) to bu¡er B
(80% CH3CN, 20% H2O, 0.4% CH3COOH, 0.005% C4HF7O2). The
column eluent was fractionated through a splitting Tee (Valco Instru-
ments, Houston, TX). 95% of the £ow was collected for Cerenkov
counting and 5% was used for MS/MS. Cerenkov counting was per-
formed on a Beckman LS 6500. Flow splitting was essentially per-
formed as previously described [23,24]. Mass spectrometry was con-
ducted on a Finnigan MAT TSQ 7000 (San Jose, CA) with a standard
ionization source [25]. The system was con¢gured so that after £ow
splitting the remaining eluent was sprayed directly into the ionization
source. Under control of the Instrument Control Language (Finnigan)
software, MS/MS was performed on selected peptides above a speci-
¢ed threshold in an automated fashion as described previously [25].
Peptide fragmentation spectra were analyzed using SEQUEST
[26], where the experimental data was correlated with theoretical
spectra from the OWL database (http://www.biochem.ucl.ac.uk/bsm/
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Fig. 1. Schematic diagram showing the domains of Stat3Ltc as de-
rived from the crystal structure of the Stat3Ltc homodimer bound
to DNA [17].
Fig. 2. Puri¢cation of the recombinant, phosphorylated Stat3Ltc.
An SDS-polyacrylamide (10%) gel is shown. Lane 1, uninduced
Stat3Ltc transformed cells; lane 2, induced Stat3Ltc transformed
cells; lane 3, supernatant of sonication of induced cells; lane 4, pel-
let of sonication of induced cells; lane 5, protein precipitated with
35% saturated ammonium sulfate at 0‡C.
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dbbrowser/OWL/OWL.html) and a FASTA formatted ¢le containing
only the STAT3Ltc amino acid sequence.
2.4. Determination of protein concentration
The puri¢ed protein was quantitated by its absorbance at 280 nm.
The extinction coe⁄cient O280 was calculated according to [27]:
O280 = (5700UW+1300UY)/molecular weight with W = number of
tryptophans, Y = number of tyrosines. For Stat3Ltc the value of O280
was 0.74 assuming a molecular weight of 136 kDa for the dimeric
protein.
2.5. Immunoblot analysis
A Western blot of the supernatant of sonication and of puri¢ed
protein was ¢rst developed with the monoclonal anti-phosphotyrosine
antibody pY20 (Santa Cruz). Subsequently bound antibodies were
removed by washing the membrane for 1 h in stripping bu¡er (62.5
mM Tris-HCl, pH 6.7, 2% SDS, 100 mM 2-mercaptoethanol).
Next the blot was developed with the polyclonal anti-Stat3 antibody
K15 (Transduction Laboratories). The detection was performed by
enhanced chemoluminescence (ECL, Amersham). The secondary
horseradish peroxidase-conjugated antibodies were obtained from
Promega.
2.6. Electrophoretic mobility shift assay
20 Wl of reaction volume contained binding bu¡er (10 mM Tris-
HCl, pH 7.5, 1 mM DTT, 0.2 mM PMSF, 0.1 mM EDTA, 5%
glycerol, 50 mM NaCl, 0.1% NP-40, 5 mM MgCl2), 0.5 fmol radio-
labelled DNA (see below), 2.0 fmol puri¢ed Stat3Ltc protein, 20 ng
bovine serum albumin (BSA) and the indicated amounts of unlabelled
DNA. The reaction mix was incubated for 30 min at room temper-
ature. Then the reaction products were loaded on a 4% polyacryl-
amide gel (1.5 mm thick) containing 0.25UTris-borate/EDTA. Before
loading the gel had been prerun at 15 V/cm for 30 min at 4‡C. After
loading the gels were run for another 3.5 h at 4‡C, dried and exposed
to X-ray ¢lm overnight.
2.7. Binding site oligonucleotides
Oligonucleotides with the trityl group cleaved o¡ were obtained in
quantities of 1 Wmol from the DNA synthesis facility, EMBL Heidel-
berg. The oligonucleotides were puri¢ed by anion exchange chroma-
tography. Oligonucleotide concentrations were determined assuming
that A260 = 1.0 corresponds to 40 Wg/ml of single stranded oligonucleo-
tide. 1 mM solutions of complementary oligonucleotides were hybrid-
ized for 12 h in 5 mM Tris-HCl, pH 8.0, 50 mM KCl, 10 mM MgCl2,
after denaturation at 95‡C. 5 pmol of duplex DNA was labelled with
[K-32P]dATP to a speci¢c activity of about 2.25 WCi/fmol using poly-
nucleotide kinase [28]. Unincorporated nucleotides were removed by
gel chromatography (G25 spin columns; Pharmacia). The following
fragments were used as probes (core binding sites are underlined):
M67, TGCATTTCCCGTAAATCT [29]; acute phase response ele-
ment (APRE), AGCTTCCTTCTGGGATTCCT [30].
3. Results
3.1. Expression and puri¢cation of tyrosine phosphorylated
Stat3Ltc
We expressed Stat3Ltc protein in the E. coli strain
BL21(DE3)TKB1 (Fig. 2, lanes 1, 2) at high levels. To obtain
soluble protein it was essential to induce the expression at
room temperature. The expressed protein had the expected
molecular weight of about 70 kDa and about 30% of the
protein was obtained in soluble form after sonication (Fig.
2, lanes 3, 4). After DNA removal and ammonium sulfate
precipitation the protein was about 90% pure (Fig. 2, lane
5). A gel chromatography step removed smaller proteins
with molecular weights between 25 and 50 kDa (Fig. 3A,B).
Fractions of the major peak contained 98% pure protein. N-
terminal sequencing con¢rmed the identity of Stat3Ltc. Immu-
noblots with an anti-phosphotyrosine antibody (pY20) and
subsequently with an anti-Stat3 antibody (K15) showed that
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Fig. 4. Immunoblot analysis of Stat3Ltc. Supernatant of the sonica-
tion and puri¢ed Stat3Ltc protein were run on a 10% SDS-poly-
acrylamide gel and transferred to nitrocellulose membrane. A: De-
velopment with anti-phosphotyrosine monoclonal antibody pY20
(1:1000-fold dilution) using enhanced chemoluminescence. B: Rede-
velopment with the anti-Stat3 polyclonal antibody K15 (1:1000-fold
dilution) using enhanced chemoluminescence.
Fig. 3. Puri¢cation of Stat3Ltc by gel ¢ltration chromatography. A: After precipitation with 35% saturated ammonium sulfate and dialysis
overnight against bu¡er D, Stat3Ltc was loaded on a Pharmacia Superose 12 HR 10/30 column in bu¡er D. Flow rate, 0.5 ml/min; fraction
size, 0.5 ml. B: A 10% SDS-polyacrylamide gel shows fractions 19^29 of the gel chromatography run (A).
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a number of proteins of di¡erent molecular weights had been
phosphorylated by the Elk receptor tyrosine kinase domain
(Fig. 4A, lane 1). One of these phosphorylated proteins was
puri¢ed and clearly identi¢ed as Stat3Ltc (Fig. 4A,B, lanes 2).
3.2. Phosphorylated Stat3Ltc forms functional homodimers
The retention on a gel ¢ltration column of phosphorylated
Stat3Ltc was compared with that of puri¢ed Stat3Ltc, which
had been expressed without the tyrosine kinase domain of the
Elk receptor. The gel ¢ltration column had been calibrated
with BSA (dimer 132 kDa, monomer 66 kDa) and cyto-
chrome c (12.4 kDa). Phosphorylated Stat3Ltc was running
as a 140 kDa protein while unphosphorylated Stat3Ltc had a
retention pro¢le equivalent to about 60 kDa (Fig. 5), suggest-
ing that Stat3Ltc can form a stable homodimer.
3.3. Determination of Stat3Ltc phosphorylation sites
Q-32P-Labelled Stat3Ltc was used to identify the exact sites
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Fig. 6. 1: The mass spectrometric base peak of trypsin (A) and AspN/trypsin (E) digested peptides separated by microbore HPLC. B and F
show the Cerenkov counts in the fractions that were collected post-HPLC separation by £ow spliting the column eluate, indicating the precence
of 32P-containing peptides. Panel C shows the trace of all occurences where ions with a m/z ratio of 866.5 þ 0.25 amu eluted. 866.5 amu is the
triply charged mass of the peptide YCacrylRPESQEHPEADPGSAAPYphosLK (see 6.2A). Likewise, panel D shows the trace where ions with
913.9 þ 0.25 amu eluted. 913.9 amu is the doubly charged mass of the peptide VVENLQDDFDFNYphosK (see 6.2B). G shows where ions with
549.8 þ 0.25 amu eluted; 549.8 amu is the doubly charged mass of the peptide DPGSAAPYphosLK (see 6.2C). Cacryl = cysteine-acrylamide ad-
duct, vmass 71; Yphos = phosphotyrosine vmass 80. 2: Tandem mass spectra of identi¢ed phosphopeptides. Fragmentation pattern of the pep-
tides (A) YCacrylRPESQEHPEADPGSAAPYphosLK, m/z 866.53, (B) VVENLQDDFDFNYphosK, 913.92, and (C) DPGSAAPYphosLK,
549.82. In each MS/MS spectrum the doubly or triply charged parent ion is indicated. Panel B shows the parent ion the loss of a phosphate
(340 m/z) at m/z 873.6.
Fig. 5. Size exclusion chromatography using a Pharmacia Superose
12 HR 10/30 column. Protein standards were BSA (132 kDa, 66
kDa) and cytochrome c (12.4 kDa). Solid line, phosphorylated
Stat3Ltc; dotted line, non-phosphorylated Stat3Ltc.
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of phosphorylation (cf. Section 2). After the puri¢ed 32P-la-
belled protein was ¢rst digested with trypsin two major peaks
were detected by Cerenkov counting (Fig. 6.1B). Two phos-
phopeptides were identi¢ed with the following sequences:
(K)YCacrylRPESQEHPEADPGSAAPYphosLK (Cacrylamide-
aa686; Yphosphate- aa705) and (K)VVENLQDDFDFNYphosK
(Yphosphate-aa176), see Fig. 6.2A,B respectively. Both peptide
masses, a triply charged 866.5 (m/z) and doubly charged 913.9
(m/z) respectively (Fig. 6.1C,D), aligned with the Cerenkov
peaks (Fig. 6.1B) associating the presence of 32P with these
peptides. To unambiguously assign the phosphorylation site
of the peptide in Cerenkov peak #1 to tyrosine residue 705, a
second digestion was performed with AspN and trypsin. This
digestion was expected to only reveal the peptide DPGSAA-
PYphosLK during an LC-MS/MS run, since the small hydro-
philic peptide DFNYphosK (aa176) was not retained by the
C18 column under the conditions used. Indeed, the subse-
quent digestion of a Stat3Ltc sample with AspN and trypsin
revealed one major peak containing 32P (Fig. 6.1F, doubly
charged 549.8 m/z). MS/MS sequencing of the 32P-containing
peptide (m/z 549.8) yielded the sequence DPGSAAPYphosLK
(Fig. 6.2C), thus con¢rming the phosphorylation site of resi-
due Y 705, identi¢ed in the ¢rst analysis.
3.4. DNA binding
The phosphorylated Stat3Ltc was able to bind to Stat3
DNA binding sites in a bandshift assay that was performed
with 32P-labelled, double stranded DNA fragments containing
a very strong, mutant (M67) and a wild type (APRE) binding
site [29,30]. As expected Stat3Ltc showed the strongest inter-
action with M67, while APRE was bound weaker. (Fig. 7,
lanes 1, 8). In both cases the binding was speci¢c, as the
unlabelled DNA fragments could competitively bind against
the respective 32P-labelled fragments to Stat3Ltc (Fig. 7, lanes
2^7, 9^14). M67 binding could still be observed when unla-
belled probe was used in a 100-fold excess while APRE bind-
ing could not be observed any more in this case (Fig. 7, lanes
7, 14). Stat3Ltc could not bind to a NF-UB P52 response
element (Fig. 7, lane 16).
4. Discussion
Bacterial expression of a soluble fragment of Stat3L crit-
ically depends on the fragment size. Initially we tried to ex-
press full length clones of murine Stat3, Stat4 and Stat5 in E.
coli using a T7-RNA polymerase based expression system
(pET, Novagen) [31]. Although we could express large
amounts of protein, all expression conditions, including a va-
riety of media, resulted in the presence of 100% of the protein
in inclusion bodies. Vinkemeier et al. [32] achieved the bacte-
rial expression of a soluble fragment of Stat1L lacking the N-
domain. Following their approach we selected N-terminally
truncated fragments of murine Stat3L, Stat4 and Stat5 and
tested their expression in E. coli. The largest amount of solu-
ble protein was obtained for Stat3Ltc, starting at Gly127. This
residue is part of a £exible linker connecting the core of the
Stat molecule to the N-domain [16^18].
Compared to Stat3 the natural splice variant Stat3L has a
shortened carboxyl terminal transactivation domain [14]. The
transactivation domain of Stat3 is 48 residues longer, highly
acidic and probably poorly structured. Furthermore it had
been shown for Stat1, Stat3 and Stat5 that removal of the
transactivation domain results in a decreased dephosphoryla-
tion rate resulting in increased DNA binding [10,14,33]. Stable
phosphorylation was essential for our aim to produce func-
tional STAT protein for crystallization studies and therefore
the short variant of Stat3L was chosen.
Stat1 and Stat3 can be activated by ligands binding to the
epidermal growth factor (EGF) receptor [34]. Correspond-
ingly the N-terminally truncated Stat1L fragment has been
activated in vitro using the tyrosine kinase activity of immu-
noprecipitated EGF receptor from A431 cells [32,35]. This
approach resulted in yields of up to 75% of phosphorylated
protein. The activation of Stat3Ltc with immunoprecipitated
EGF receptor was not successful in our hands. Cao et al. [36]
have demonstrated that Src might be involved in the activa-
tion of Stat3 through the EGF receptor. Our attempts to
activate Stat3Ltc with Src were successful, but the yields
were very low (not shown).
An alternative to these in vitro activations is the in vivo
activation through the tyrosine kinase activity of the Elk re-
ceptor, a member of the Eph receptor family [37,38]. The
strain BL21(DE3)TBK1 (Stratagene) carries an expression
plasmid for this tyrosine kinase domain, which is induced
following the expression of the Stat protein. Our simple puri-
¢cation protocol allowed us to prepare phosphorylated Stat3L
that was running on a gel ¢ltration column as a single peak
corresponding to the size of a dimer, while no monomer peak
could be detected (Figs. 3 and 5). This shows that all Stat3Ltc
protein coexpressed with the Elk receptor kinase domain di-
merizes and is probably nearly quantitatively phosphorylated.
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Fig. 7. Stat3Ltc binds to mutant and wild type STAT DNA binding
sites. The labelled probes only (lanes 1, 8, 15) or reaction mixes of
Stat3Ltc with the probes (lanes 2^7, 9^14, 16) were analyzed by gel
retardation. Unlabelled probe was added to the reaction mixes in
excess: 5-fold (lanes 3, 10), 10-fold (lanes 4, 11), 20-fold (lanes 5,
12), 50-fold (lanes 6, 13) and 100-fold (lanes 7, 14).
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This is an important advantage of the in vivo activation com-
pared to the less e⁄cient in vitro activation [32], where a
chromatographic step to separate phosphorylated from non-
phosphorylated protein is necessary. Our puri¢cation proce-
dure includes gel ¢ltration chromatography, but crystals of
the protein:DNA complex [17] were also obtained without
the ¢nal gel ¢ltration step. The speci¢c binding to natural
DNA target sites con¢rmed that the bacterially expressed pro-
tein not only dimerized but also retained its DNA binding
ability.
In Stat3L Y705 is the only physiological tyrosine phospho-
rylation site [39]. It is responsible for the reciprocal binding of
the monomers. Mass spectrometry identi¢ed this residue as
the major phosphorylation site of Stat3Ltc (Fig. 6). Y176
was identi¢ed as the only other phosphorylated residue of
Stat3Ltc (Fig. 6). This residue is located at the end of helix
K1 of the four helix bundle and points into the solvent [17].
Cerenkov counting estimated its phosphorylation site has a
low occupancy, which is consistent with our ¢nding that no
electron density of a phosphate group at Y176 was observed
in the electron density map of the Stat3Ltc:DNA cocrystals
[17]. Nevertheless the speci¢city of the kinase activity of the
Elk receptor tyrosine kinase domain seemed to be lower in the
case of Stat3Ltc than that of the immunoprecipitated EGF
receptor from A431 cells in the case of the N-terminally trun-
cated Stat1L. Here only the expected Y701 had been phos-
phorylated [32].
Stat1 and Stat3 probably bind through their SH2 domains
to phosphotyrosines outside the catalytic center of the EGF
receptor [40,41], similar to their speci¢c interactions with
phosphotyrosines on the cytoplasmic domains of cytokine re-
ceptors [42]. In our bacterial expression system the receptor
component with its docking site as an element of substrate
speci¢city is missing. The kinase and its substrate are there-
fore not held in a rigid con¢guration by the receptor, which
might render Y176 of Stat3Ltc a substrate of the kinase do-
main. Alternatively it is possible that the di¡erence in the
phosphorylation patterns between the EGF receptor and the
Elk receptor tyrosine kinase domain re£ects a real di¡erence
in speci¢city of the kinase activities of these two protein-ty-
rosine kinase receptors.
Our in vivo activation procedure allows the easy prepara-
tion of large amounts of active Stat3 protein. Using the same
procedure we also observed the phosphorylation of a N-ter-
minally truncated fragment of Stat5 (not shown) and indeed,
all activated STATs might be obtained by this approach. The
easy accessibility to large quantities of active STAT proteins
should prove bene¢cial for further investigations such as
structural studies and large-scale drug screens. Furthermore
protein-tyrosine kinase receptors activate many other e¡ector
proteins [43,44]. It is therefore intriguing to investigate if any
of these proteins can also be activated in vivo by the Elk
receptor tyrosine kinase domain.
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